Drug Delivery Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific drug delivery device market will see moderate growth over the forecast period, fueled by the increasing availability of lower-cost generic drug delivery devices and the expanding diabetes and asthma patient populations. However, this market continues to be limited—particularly in China and India—by strong cost constraints that impede the uptake of higher priced products.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for drug delivery devices in Asia Pacific across a 10-year period.
Table of contents
- Drug Delivery Devices - Market Insights - Asia Pacific (Supplemental)
